Breast Cancer Ultrasound Device Gets Favorable Panel Recommendation

Devices & Diagnostics Letter
An FDA advisory panel unanimously recommended approval of a new tool for detecting breast cancer, but advised against Class I status for a preamendment device used for the same purpose.

To View This Article:


Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00